Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
Model Medicines’ GALILEO™ platform is delivering breakthroughs beyond antivirals. The company is advancing its pipeline to address unmet medical needs in oncology, rare diseases, and other therapeutic ...
Université Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d’Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, 4 place du général Leclerc, Orsay 91401, France Department of ...
This analysis revealed that 221 biological processes, 82 cellular components, 63 molecular functions, and 36 KEGG pathways were employed to identify three therapeutic candidate genes, including CDC20, ...